References
- Lamberti MJ, Getz K. Profiles of new approaches to improving the efficiency and performance of pharmaceutical drug development. 2015 [cited 2019 Jun 11]. Available from: http://csdd.tufts.edu/files/uploads/CSSD_PhRMAWhitePaper_FINAL.pdf
- Smietana K, Siatkowski M, Møller M. Trends in clinical success rates. Nat Rev Drug Discov. 2016;15:379–380.
- Mann DL. The rising cost of developing cardiovascular therapies and reproducibility in translational research: do not blame it (all) on the bench. JACC Basic Transl Sci. 2017;2:627–629.
- Cirit M, Stokes CL. Maximizing the impact of microphysiological systems with in vitro-in vivo translation. Lab Chip. 2018;18:1831–1837.
- Huh D, Torisawa YS, Hamilton GA, et al. Microengineered physiological biomimicry: organs-on-chips. Lab Chip. 2012;12:2156–2164.
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772.
- Theocharis AD, Skandalis SS, Gialeli C, et al. Extracellular matrix structure. Adv Drug Deliv Rev. 2016;97:4–27.
- Yi S, Ding F, Gong L, et al. Extracellular matrix scaffolds for tissue engineering and regenerative medicine. Curr Stem Cell Res Ther. 2017;12:233–246.
- Harrison RG, Greenman MJ, Franklin P, et al. Observations of the living developing nerve fiber. Anat Rec. 1907;1:116–128.
- Breslin S, O’Driscoll L, Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today. 2013;18:240–249.
- McLean IC, Schwerdtfeger LA, Tobet SA, et al. Powering ex vivo tissue models in microfluidic systems. Lab Chip. 2018;18:1399–1410.
- Watson DE, Hunziker R, Wikswo JP. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology. Exp Biol Med (Maywood). 2017;242:1559–1572.
- Gupta N, Liu JR, Patel B, et al. Microfluidics-based 3D cell culture models: utility in novel drug discovery and delivery research. Bioeng Transl Med. 2016;1:63–81.
- Li DW, He FL, He J, et al. From 2D to 3D: the morphology, proliferation and differentiation of MC3T3-E1 on silk fibroin/chitosan matrices. Carbohydr Polym. 2017;178:69–77.
- Van Duinen V, Trietsch SJ, Joore J, et al. Microfluidic 3D cell culture: from tools to tissue models. Curr Opin Biotechnol. 2015;35:118–126.
- Casey A, Gargotti M, Bonnier F, et al. Chemotherapeutic efficiency of drugs in vitro: comparison of doxorubicin exposure in 3D and 2D culture matrices. Toxicol In Vitro. 2016;33:99–104.
- Valente KP, Khetani S, Kolahchi AR, et al. Microfluidic technologies for anticancer drug studies. Drug Discov Today. 2017;22:1654–1670.
- Kolahchi AR, Mohtaram NK, Modarres HP, et al. Microfluidic-based multi-organ platforms for drug discovery. Micromachines. 2016;7:162.
- Yu G, Lima J, Choia MS, et al. From microchannels to microphysiological systems: development of application specific devices. Microelectron Eng. 2018;202:9–18.
- SE P, Georgescu A, Huh D. Organoids-on-a-chip. Science. 2019;364:960–995.
- Ingber DE. Developmentally inspired human ‘organs on chips’. Development. 2018;145: pii: dev156125.
- Shuler ML. Organ-, body- and disease-on-a-chip systems. Lab Chip. 2017;17:2345–2346.
- Esch EW, Bahinski A, Huh D. Organ-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov. 2015;14:248–260.
- Ewart L, Fabre K, Chakilam A, et al. Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective. Exp Biol Med (Maywood). 2017;242:1579–1585.
- Ewart L, Dehne EM, Fabre K, et al. Application of microphysiological systems to enhance safety assessment in drug discovery. Annu Rev Pharmacol Toxicol. 2018;58:65–82.
- Akhtar AA, Sances S, Barrett R, et al. Organoid and organ-on-a-chip systems: new paradigms for modeling neurological and gastrointestinal disease. Curr Stem Cell Rep. 2017;3:98–111.
- Wu MH, Huang SB, Lee GB. Microfluidic cell culture systems for drug research. Lab Chip. 2010;10:939–956.
- Mehling M, Tay S. Microfluidic cell culture. Curr Opin Biotechnol. 2014;25:95–102.
- AUR A, Geng C, Fu M, et al. The role of microfluidics for organ on chip simulations. Bioengineering (Basel). 2017;4: pii: E39.
- Bowes J, Brown AJ, Hamon J, et al. Reducing safety-related drug attrition: the use of in vitro pharmacological profiling. Nat Rev Drug Discov. 2012;11:909–922.
- Harmonised Tripartite ICH. Guideline. Safety pharmacology studies for human pharmaceuticals. S7A, 2000 [cited 2019 Jun 11]. www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S7A/Step4/S7A_Guideline.pdf
- Harmonised Tripartite ICH. Guideline. The non-clinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. S7B. 2005 [Cited 2019 June 11]. www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S7A/Step4/S7A_Guideline.pdf
- Harmonised Tripartite ICH. Guideline. Nonclinical evaluation for anticancer pharmaceuticals. S9. 2009 [cited 2019 Jun 11] www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S9/Step4/S9_Step4_Guideline.pdf
- Park K, Lee Y, Seo J. Recent advances in high-throughput platforms with engineered biomaterial microarrays for screening of cell and tissue behavior. Curr Pharm Des. 2018;24:5458–5470.
- Probst C, Schneider S, Loskill P. High-throughput organ-on-a-chip systems: current status and remaining challenges. Curr Opin Biotechnol. 2018;6:33–41.
- Zhang B, Radisic M. Organ-on-a-chip devices advance to market. Lab Chip. 2017;17:2395–2420.
- Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer. 2017;1:46–54.
- Yi HG, Lee H, Cho DW. 3D Printing of organs-on-chips. Bioengineering (Basel). 2017;4: pii: E10.
- Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016;51:8–12.
- Guillotin B, Guillemot F. Cell patterning technologies for organotypic tissue fabrication. Trends Biotechnol. 2011;29:183–190.
- Ahadian S, Civitarese R, Bannerman D, et al. Organ-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies. Adv Healthc Mater. 2018;7. doi:10.1002/adhm.201800734.
- Bartley BA, Kim K, Medley JK. Synthetic biology: engineering living systems from biophysical principles. Biophys J. 2017;112:1050–1058.
- Taylor DA, Sampaio LC, Ferdous Z, et al. Decellularized matrices in regenerative medicine. Acta Biomater. 2018;74:74–89.
- Saglam-Metiner P, Gulce-Iz S, Biray-Avci C. Bioengineering-inspired three-dimensional culture systems: organoids to create tumor microenvironment. Gene. 2019;686:203–212.
- Lee SH, Hyun B-H. Advances in dynamic microphysiological organ-on-a-chip: design principle and its biomedical application. J Ind Eng Chem. 2018;71:65–77.
- Yang Q, Lian Q, Perspective: XF. Fabrication of integrated organ-on-a-chip via bioprinting. Biomicrofluidics. 2017;11:031301.
- Sontheimer-Phelps A, Hassell BA, Ingber DE. Modelling cancer in microfluidic human organs-on-chips. Nat Rev Cancer. 2019;19:65–81.
- Bovard D, Iskandar A, Luettich K, et al. Organs-on-a-chip: A new paradigm for toxicological assessment and preclinical drug development. Toxicol Res Appl. 2017;1:1–16.
- van Meer BJ, de Vries H, Firth KSA, et al. Small molecule absorption by PDMS in the context of drug response bioassays. Biochem Biophys Res Commun. 2017;482:323–328.
- Marx U, Andersson TB, Bahinski A, et al. Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. ALTEX. 2016;33:272–321.
- Li X, He J, Zhang W, et al. Additive manufacturing of biomedical constructs with biomimetic structural organizations. Materials (Basel). 2016;9: pii: E909.
- Williams D, Thayerb P, Martinezb H, et al. A perspective on the physical, mechanical and biological specifications of bioinks and the development of functional tissues in 3D bioprinting. Bioprinting. 2018;9:19–36.
- Derakhshanfar S, Mbeleck R, Xu K, et al. 3D bioprinting for biomedical devices and tissue engineering: A review of recent trends and advances. Bioact Mater. 2018;3:144–156.
- Yu F, Choudhury D. Microfluidic bioprinting for organ-on-a-chip models. Drug Discov Today. 2019;1248–1257. doi: 10.1016/j.drudis.2019.03.025.
- Savoji H, Mohammadi MH, Rafatian N, et al. Cardiovascular disease models: A game changing paradigm in drug discovery and screening. Biomaterials. 2019;198:3–26.
- Ghosh D, Mehta N, Patil A, et al. Ethical issues in biomedical use of human embryonic stem cells (hESCs). J Reprod Health Med. 2016;2:537–547.
- Loskill P, Huebsch N. Engineering tissues from induced pluripotent stem cells. Tissue Eng Part A. 2019;25:707–770.
- Raasch M, Fritsche E, Kurtz A, et al. Microphysiological systems meet hiPSC technology - New tools for disease modeling of liver infections in basic research and drug development. Adv Drug Deliv Rev. 2018; pii:S0169-409X(18)30147–9. doi:10.1016/j.addr.2018.06.008
- Jin MZ, Han RR, Qiu GZ, et al. Organoids: an intermediate modeling platform in precision oncology. Cancer Lett. 2018;414:174–180.
- Young AT, Rivera KR, Erb PD, et al. Monitoring of microphysiological systems: integrating sensors and real-time data analysis toward autonomous decision-making. ACS Sens. 2019;4:1454–1464.
- Derkus B. Applying the miniaturization technologies for biosensor design. Biosens Bioelectron. 2016;79:901–913.
- Barrile R, van der Meer AD, Park H, et al. Organ-on-Chip recapitulates thrombosis induced by an anti-CD154 monoclonal antibody: translational potential of advanced microengineered systems. Clin Pharmacol Ther. 2018;104:1240–1248.
- Fitzpatrick S. Determining the predicative ability of in vitro microphysiological systems to answer critical regulatory questions. Meeting Presentation. 2007 [cited 2019 June 11]. Available from: www.ema.europa.eu/documents/presentation/presentation-determining-predicative-ability-vitro-microphysiological-systems-answer-critical_en.pdf
- Low LA, Tagle DA. Organs-on-chips: progress, challenges, and future directions. Exp Biol Med (Maywood). 2017;242:1573–1578.
- Ishida S. Organs-on-a-chip: current applications and consideration points for in vitro ADME-Tox studies. Drug Metab Pharmacokinet. 2018;33:49–54.
- Mak IW, Evaniew N, Ghert M. Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014;6:114–118.
- Maschmeyer I, Lorenz AK, Schimek K, et al. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip. 2015;15:2688–2699.
- Ataç B, Wagner I, Horland R, et al. Skin and hair on-a-chip: in vitro skin models versus ex vivo tissue maintenance with dynamic perfusion. Lab Chip. 2013;13:3555–3561.
- Materne EM, Ramme AP, Terrasso AP, et al. A multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing. J Biotechnol. 2015;205:36–46.
- Huh D, Kim HJ, Fraser JP, et al. Microfabrication of human organs-on-chips. Nat Protoc. 2013;8:2135–2157.
- Wikipedia. Scanning probe lithography. 2017 [cited 2019 Jun 11]. Available from: https://en.wikipedia.org/wiki/Scanning_probe_lithography
- Mosig AS. Organ-on-chip models: new opportunities for biomedical research. Future Sci OA. 2016;3:FSO130.
- Balijepalli A, Sivaramakrishan V. Organs-on-chips: research and commercial perspectives. Drug Discov Today. 2017;22:397–403.
- Kankala RK, Wang SB, Chen AZ. Microengineered organ-on-a-chip platforms towards personalized medicine. Curr Pharm Des. 2019;24:5354–5366.
- Phan DT, Bender RHF, Andrejecsk JW, et al. Blood-brain barrier-on-a-chip: microphysiological systems that capture the complexity of the blood-central nervous system interface. Exp Biol Med (Maywood). 2017;242:1669–1678.
- Booth R, Kim H. Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). Lab Chip. 2012;12:1784–1792.
- Griep LM, Wolbers F, de Wagenaar B, et al. BBB on CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices. 2013;5:145–150.
- Shao X, Gao D, Chen Y, et al. Development of a blood-brain barrier model in a membrane-based microchip for characterization of drug permeability and cytotoxicity for drug screening. Anal Chim Acta. 2016;934:186–193.
- Herland A, van der Meer AD, FitzGerald EA, et al. Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3d human blood-brain barrier on a chip. PLoS One. 2016;11:e0150360.
- Vatine GD, Barrile R, Workman MJ, et al. Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications. Cell Stem Cell. 2019 Jun 6;24:995–1005.e6.
- Meijer TG, Naipal KA, Jager A, et al. Ex vivo tumor culture systems for functional drug testing and therapy response prediction. Future Sci OA. 2017;3:FSO190.
- Sun W, Luo Z, Lee J, et al. Organ-on-a-chip for cancer and immune organs modeling. Adv Health Mater. 2019;e1801363. doi:10.1002/adhm.201801363.
- Choi Y, Hyun E, Seo J, et al. A microengineered pathophysiological model of early-stage breast cancer. Lab Chip. 2015;15:3350–3357.
- Lee IC. Cancer-on-a-chip for drug screening. Curr Pharm Des. 2018;24:5407–5418.
- Sleeboom JJF, Eslami Amirabadi H, Nair P, et al. Metastasis in context: modeling the tumor microenvironment with cancer-on-a-chip approaches. Dis Model Mech. 2018;11: pii: dmm033100.
- Caballero D, Kaushik S, Correlo VM, et al. Organ-on-chip models of cancer metastasis for future personalized medicine: from chip to the patient. Biomaterials. 2017;149:98–115.
- Yeung CK, Himmelfarb J. Kidneys on chips: emerging technology for preclinical drug development. Clin J Am Soc Nephrol. 2019;14:144–146.
- Lee J, Kim S. Kidney-on-a-chip: A new technology for predicting drug efficacy, interactions, and drug-induced nephrotoxicity. Curr Drug Metab. 2018;19:577–583.
- Weber EJ, Chapron A, Chapron BD, et al. Development of a microphysiological model of human kidney proximal tubule function. Kidney Int. 2016;90:627–637.
- Chang SY, Weber EJ, Sidorenko VS, et al. Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. JCI Insight. 2017;2: pii: 95978.
- Weber EJ, Lidberg KA, Wang L, et al. Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity. JCI Insight. 2018;3(24):pii: 123673.
- Mann H. Organ-on-chip systems and services for generating and analyzing living 3D models of human organs. [ cited June 11, 2019]. Available from: http://3d-tissuemodels.com/wp-content/uploads/sites/189/2017/09/Nortis-3D-Tissue-Models-2017-final.pdf
- Zhao Y, Rafatian N, Wang EY, et al. Engineering microenvironment for human cardiac tissue assembly in heart-on-a-chip platform. Matrix Biol. 2019; pii:S0945-053X(18)30483–9. doi: 10.1016/j.matbio.2019.04.001
- Ugolini GS, Visone R, Cruz-Moreira D, et al. Generation of functional cardiac microtissues in a beating heart-on-a-chip. Methods Cell Biol. 2018;146:69–84.
- Kitsara M, Kontziampasis D, Agbulut O, et al. Heart on a chip: micro-nanofabrication and microfluidics steering the future of cardiac tissue engineering. Microelectron Eng. 2019;203–204:44–62.
- Lemme M, Ulmer BM, Lemoine MD, et al. Atrial-like engineered heart tissue: an in vitro model of the human atrium. Stem Cell Reports. 2018;11:1378–1390.
- Mittal R, Woo FW, Castro CS, et al. Organ-on-chip models: implications in drug discovery and clinical applications. J Cell Physiol. 2019;234:8352–8380.
- Lind JU, Busbee TA, Valentine AD, et al. Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing. Nat Mater. 2017;16:303–308.
- Jackman CP, Ganapathi AM, Asfour H, et al. Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation. Biomaterials. 2018;159:48–58.
- Fleischer S, Feiner R, Dvir T. Cutting-edge platforms in cardiac tissue engineering. Curr Opin Biotechnol. 2017;47:23–29.
- Taylor DA, Frazier OH, Elgalad A, et al. Building a total bioartificial heart: harnessing nature to overcome the current hurdles. Artif Organs. 2018;42:970–982.
- Barko PC, McMichael MA, Swanson KS, et al. The gastrointestinal microbiome: A review. J Vet Intern Med. 2018;32:9–25.
- Bein A, Shin W, Jalili-Firoozinezhad S, et al. Microfluidic organ-on-a-chip models of human intestine. Cell Mol Gastroenterol Hepatol. 2018;5:659–668.
- Kasendra M, Tovaglieri A, Sontheimer-Phelps A, et al. Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids. Sci Rep. 2018;8:2871.
- Bein A, Shin W, Jalili-Firoozinezhad S, et al. Microfluidic organ-on-a-chip models of human intestine. Cell Mol Gastroenterol Hepatol. 2018;5:659–668.
- Workman MJ, Gleeson JP, Troisi EJ, et al. Enhanced utilization of induced pluripotent stem cell-derived human intestinal organoids using microengineered chips. Cell Mol Gastroenterol Hepatol. 2018;5:669–677.
- Ehrlich A, Duche D, Ouedraogo G, et al. Challenges and opportunities in the design of liver-on-chip microdevices. Annu Rev Biomed Eng. 2019;21:219–239.
- Nguyen-Lefebvre AT, Horuzsko A. Kupffer cell metabolism and function. J Enzymol Metab. 2015;1: pii: 101.
- Soto-Gutierrez A, Gough A, Vernetti LA, et al. Pre-clinical and clinical investigations of metabolic zonation in liver diseases: the potential of microphysiology systems. Exp Biol Med (Maywood). 2017;242:1605–1616.
- Kietzmann T. Metabolic zonation of the liver: the oxygen gradient revisited. Redox Biol. 2017;11:622–630.
- Beckwitt CH, Clark AM, Wheeler S, et al. Liver ‘organ on a chip’. Exp Cell Res. 2018;363:15–25.
- Lee-Montiel FT, George SM, Gough AH, et al. Control of oxygen tension recapitulates zone-specific functions inhuman liver microphysiology systems. Exp Biol Med (Maywood). 2017;242:1617–1632.
- Huh D, Matthews BD, Mammoto A, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328(5986):1662–1668.
- Nawroth JC, Barrile R, Conegliano D, et al. Stem cell-based lung-on-chips: the best of both worlds? Adv Drug Deliv Rev. 2018;pii: S0169-409X(18)30169–8. doi:10.1016/j.addr.2018.07.005.
- Kızılkurtlu AA, Polat T, Aydın GB. Lung on a chip for drug screening and design. Curr Pharm Des. 2018;24:5386–5396.
- Bovard D, Sandoz A, Luettich K, et al. A lung/liver-on-a-chip platform for acute and chronic toxicity studies. Lab Chip. 2018;18:3814–3829.
- Zhang YS, Oklu R, Albadawi H. Bioengineered in vitro models of thrombosis: methods and techniques. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S329–35.
- Branchford BR, Ng CJ, Neeves KB. Microfluidic technology as an emerging clinical tool to evaluate thrombosis and hemostasis. Thromb Res. 2015;136:13–19.
- Jain A, van der Meer AD, Papa AL, et al. Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endothelium. Biomed Microdevices. 2016;18:73.
- Rogal J, Probst C, Loskill P. Integration concepts for multi-organ chips: how to maintain flexibility?! Future Sci OA. 2017;3:FSO180.
- Coppeta JR, Mescher MJ, Isenberg BC, et al. A portable and reconfigurable multi-organ platform for drug development with onboard microfluidic flow control. Lab Chip. 2016;17:134–144.
- Wikswo JP. The relevance and potential roles of microphysiological systems in biology and medicine. Exp Biol Med (Maywood). 2014;239:1061–1072.
- U.S. Environmental Protection. Agency (EPA). Guidelines for reproductive toxicity risk assessment. October 1996 [cited 2019 Jun 11]. Available from: https://www.epa.gov/sites/production/files/2014-11/documents/guidelines_repro_toxicity.pdf
- Xiao S, Coppeta JR, Rogers HB, et al. Microfluidic culture model of the human reproductive tract and 28-day menstrual cycle. Nat Commun. 2017;8:14584.
- Young AN, Moyle-Heyrman G, Kim JJ, et al. Microphysiologic systems in female reproductive biology. Exp Biol Med (Maywood). 2017;242:1690–1700.
- Lee JS, Romero R, Han YM, et al. Placenta-on-a-chip: a novel platform to study the biology of the human placenta. J Matern Fetal Neonatal Med. 2016;29:1046–1054.
- Nishiguchi A, Gilmore C, Sood A, et al. In vitro placenta barrier model using primary human trophoblasts, underlying connective tissue and vascular endothelium. Biomaterials. 2019;192:140–148.
- Yin F, Zhu Y, Zhang M, et al. A 3D human placenta-on-a-chip model to probe nanoparticle exposure at the placental barrier. Toxicol In Vitro. 2019;54:105–113.
- Prantil-Baun R, Novak R, Das D, et al. Pharmacodynamic analysis enabled microfluidically linked organ on chips. Annu Rev Pharmacol Toxicol. 2018;58:37–64.
- Kimura H, Sakai Y, Fujii T. Organ/body-on-a-chip based on microfluidic technology for drug discovery. Drug Metab Pharmacokinet. 2018;33:43–48.
- Esch MB, Smith AS, Prot JM, et al. How multi-organ microdevices can help foster drug development. Adv Drug Deliv Rev. 2014;69–70:158–169.
- Kolahchi AR, Mohtaram N-K, Modarres HP, et al. Microfluidic-based multi-organ platforms for drug discovery. Micromachines. 2016;7:162.
- Isoherranen N, Madabushi R, Huang SM. Emerging role of organ-on-a-chip technologies in quantitative clinical pharmacology evaluation. Clin Transl Sci. 2019;12:113–121.
- Wang X, Cirit M, Wishnok JS, et al. Analysis of an integrated human multi-organ microphysiological system for combined tolcapone metabolism and brain metabolomics. Anal Chem. 2019;91:8667–8675.
- Weinhart M, Hocke A, Hippenstiel S, et al. 3D organ models-revolution in pharmacological research? Pharmacol Res. 2019;139:446–451.
- Bailey J, Balls M. Recent efforts to elucidate the scientific validity of animal-based drug tests by the pharmaceutical industry, pro-testing lobby groups, and animal welfare organisations. BMC Med Ethics. 2019;20:16.
- Tannenbaum J, Bennett BT. Russell and Burch’s 3Rs then and now: the need for clarity in definition and purpose. J Am Assoc Lab Anim Sci. 2015;54:120–132.
- Gross D, Tolba RH. Ethics in animal-based research. Eur Surg Res. 2015;55:43–57.
- Arck PC. When 3 Rs meet a forth R: replacement, reduction and refinement of animals in research on reproduction. J Reprod Immunol. 2019;132:54–59.
- Goldberg A, Leist M, Hartung T. The Center for Alternatives to Animal Testing(CAAT) in the USA and Europe. In: Balls M, Combes M, Worth A, editors. The History of alternative test methods in toxicology (chapter 2.11). Elsevier; 2019. p. 107–117. doi:10.1016/B978-0-12-813697-3.00014-7.
- Arora T, Mehta AK, Joshi V, et al. Substitute of animals in drug research: an approach towards fulfilment of 4R’s. Indian J Pharm Sci. 2011;73:1–6.
- Jewett MC, Ellis T. Editorial overview: synthetic biology: frontiers in synthetic biology. Curr Opin Chem Biol. 2017;40:A1–A3.
- Edri R, Gal I, Noor N, et al. Personalized hydrogels for engineering diverse fully autologous tissue implants. Adv Mater. 2019;31:e1803895.
- Noor N, Shapira A, Edri R, et al. 3D printing of personalized thick and perfusable cardiac patches and hearts. Adv Sci. 2019;6:1900344.
- Wikswo JP. Looking to the future of organs-on-chips: interview with Professor John Wikswo. Future Sci OA. 2017;3:FSO163.
- Shanti A, Teo J, Stefanini C. In vitro immune organs-on-chip for drug development: a review. Pharmaceutics. 2018;10: pii: E278.
- Junaid A, Mashaghi A, Hankemeiera T, et al. An end-user perspective on organ-on-a-chip: assays and usability aspects. Curr Opin Biomed Eng. 2017;1:15–22.
- Liu Y, Gill E, Sher Huang YY. Microfluidic on-chip biomimicry for 3D cell culture: a fit-for-purpose investigation from the end user standpoint. Future Sci OA. 2017;3:FSO173.
- U.S. Food and Drug Administration. FDA predictive toxicology roadmap. December 2017 [cited 2019 Jun 11]. Available from: www.fda.gov/downloads/ScienceResearch/SpecialTopics/RegulatoryScience/UCM587831.pdf
- Wang A. Ethics of organs on chips. 2014 [cited 2019 Jun 11]. Available from: www.pitt.edu/~axw5/Writing%20Assignment%203.pdf
- Cheluvappa R, Scowen P, Eri R. Ethics of animal research in human disease remediation, its institutional teaching; and alternatives to animal experimentation. Pharmacol Res Perspect. 2017;5:e00332.
- Constitution of the world health organization. 1946 [cited 2019 Jun 11]. Available from: www.who.int/governance/eb/who_constitution_en.pdf
- Kane KIW, Moreno EL, Hachi S, et al. Automated microfluidic cell culture of stem cell derived dopaminergic neurons. Sci Rep. 2019;9:1796.
- Rothbauer M, Rosser JM, Zirath H, et al. Tomorrow today: organ-on-a-chip advances towards clinically relevant pharmaceutical and medical in vitro models. Curr Opin Biotechnol. 2019;55:81–86.
- Ingber DE. Reverse engineering human pathophysiology with organs-on-chips. Cell. 2016;164:1105–1109.
- Zhao Y, Kankala RK, Wang SB, et al. Multi-organs-on-chips: towards long-term biomedical investigations. Molecules. 2019;24(4): pii: E675.
- Franzen N, van Harten WH, Retèl VP, et al. Impact of organ-on-a-chip technology on pharmaceutical R&D costs. Drug Discov Today. 2019 Jun 8:pii: S1359-6446(19)30042-X. doi:10.1016/j.drudis.2019.06.003
- Haddrick M, Simpson PB. Organ-on-a-chip technology: turning its potential for clinical benefit into reality. Drug Discov Today. 2019 May;24:1217–1223.
- World Economic Forum. Top 10 emerging technologies of 2016. [ Cited 2019 June 11]. Available from: http://www3.weforum.org/docs/GAC16_Top10_Emerging_Technologies_2016_report.pdf